Literature DB >> 27140404

A regional approach for CAR T-cell therapy for mesothelioma: from mouse models to clinical trial.

Marissa Mayor1, Masha Zeltsman1, Erin McGee1, Prasad S Adusumilli1,2.   

Abstract

Entities:  

Keywords:  adoptive T-cell therapy; chimeric antigen receptor; mesothelin

Mesh:

Substances:

Year:  2016        PMID: 27140404     DOI: 10.2217/imt-2016-0008

Source DB:  PubMed          Journal:  Immunotherapy        ISSN: 1750-743X            Impact factor:   4.196


× No keyword cloud information.
  6 in total

Review 1.  The basics of CAR T design and challenges in immunotherapy of solid tumors - Ovarian cancer as a model.

Authors:  Xuequn Xu; Jin Qiu; Yi Sun
Journal:  Hum Vaccin Immunother       Date:  2017-03-08       Impact factor: 3.452

2.  CAR T-cell immunotherapy of MET-expressing malignant mesothelioma.

Authors:  Thivyan Thayaparan; Roseanna M Petrovic; Daniela Y Achkova; Tomasz Zabinski; David M Davies; Astero Klampatsa; Ana C Parente-Pereira; Lynsey M Whilding; Sjoukje Jc van der Stegen; Natalie Woodman; Michael Sheaff; Jennifer R Cochran; James F Spicer; John Maher
Journal:  Oncoimmunology       Date:  2017-08-14       Impact factor: 8.110

Review 3.  Genetically engineered CAR T-immune cells for cancer therapy: recent clinical developments, challenges, and future directions.

Authors:  Sherien M El-Daly; Jihan Hussein
Journal:  J Appl Biomed       Date:  2019-02-20       Impact factor: 1.797

4.  CAR-T Cells: A Systematic Review and Mixed Methods Analysis of the Clinical Trial Landscape.

Authors:  David Pettitt; Zeeshaan Arshad; James Smith; Tijana Stanic; Georg Holländer; David Brindley
Journal:  Mol Ther       Date:  2017-11-02       Impact factor: 11.454

Review 5.  Immunological effect of local ablation combined with immunotherapy on solid malignancies.

Authors:  Yusuke Takahashi; Noriyuki Matsutani; Takashi Nakayama; Hitoshi Dejima; Hirofumi Uehara; Masafumi Kawamura
Journal:  Chin J Cancer       Date:  2017-06-07

Review 6.  Current Management and Future Perspective in Pleural Mesothelioma.

Authors:  Rajiv Shah; Laura V Klotz; Julia Glade
Journal:  Cancers (Basel)       Date:  2022-02-18       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.